SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA conducts inspection at Solara Active Pharma Sciences’ Visakhapatnam API manufacturing facility

30 Jan 2023 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at the new state-of-the-art multipurpose API manufacturing facility of Solara Active Pharma Sciences at Visakhapatnam (Vizag), Andhra Pradesh. The Agency, with its designated investigator, inspected the facility from January 23, 2023 to January 26, 2023. The inspection established that the site is in an Acceptable State of Compliance with Zero Form 483 inspectional observations from the agency.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

491.95 -7.30 (-1.46%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×